The Division of Vascular and Endovascular Surgery at Cooper University Health Care is involved in a wide variety of research into new surgical treatments for vascular disorders.
Because our surgeons are nationally recognized for their expertise in treating vascular disease, device manufacturers regularly partner with us to test new technology and techniques that promise to improve outcomes for patients with vascular disorders.
As a result, you have convenient access to leading-edge surgical treatments that our surgeons are investigating through clinical trials, right here in South Jersey.
Why Participate in a Clinical Trial at Cooper?
Being a participant in a clinical trial may allow you to benefit from advanced technology before it’s widely available to patients outside the study. You may also receive a new method of treatment that’s more effective than the standard approach.
In addition, you receive close monitoring, advice, care and support from a respected team of experts with deep understanding of your condition.
Vascular Surgery Clinical Trials Underway at Cooper
We are participating in more than 10 global clinical trials to advance new methods for minimally invasive vascular surgery. The trials that currently are recruiting patients to participate are:
Prospective, Multicenter, Single Arm Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair using the Nellix® System - The object of this study is to study the safety and effectiveness of the Nellix system for endovascular abdominal aortic aneurysm (AAA) repair. The surgeons leading this study are Jose Trani, MD, and Joseph V. Lombardi, MD, FACS
Learn More About Clinical Trials at Cooper
If you would like more information about our clinical trials or see if you might qualify to participate, please make an appointment with Cooper Vascular Surgery to discuss your options. Our physicians will be able to determine your eligibility for a particular clinical trial based on a physical examination and a one-on-one discussion.